Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | MLYCD | O95822 | 2/20 | 0.35 |
| ▸ | ATR | Q13535 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19141766 | 0.91 | CA14 (0.37) | CA14MLYCDATR | |
| SCHEMBL27051162 | 0.82 | LMNA (0.46) | — | |
| SCHEMBL22386559 | 0.81 | MLYCD (0.40) | CA14MLYCDCTSK | |
| SCHEMBL19400199 | 0.81 | MLYCD (0.38) | CA14MLYCD | |
| SCHEMBL9361432 | 0.75 | MLYCD (0.44) | MLYCD | |
| SCHEMBL1177268 | 0.74 | MAPT (0.35) | CA14 | |
| SCHEMBL2579949 | 0.73 | CTSK (0.44) | CA14MLYCDATRCTSK | |
| SCHEMBL8593140 | 0.73 | CHRM2 (0.36) | CA14MLYCDCTSK | |
| SCHEMBL29411335 | 0.73 | FAAH (0.50) | — | |
| SCHEMBL10065436 | 0.73 | MLYCD (0.41) | CA14MLYCDCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200277406-A1 | BINDING AGENT | ROCHE DIAGNOSTICS GMBH (DE) | 2020-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277406-A1 | BINDING AGENT | SSB, APBA1, SHBG | CA14 1305/4885MLYCD 4872/4885ATR 1985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.